TearScience Inc. announced on July 11 that its proprietary thermal pulsation system received FDA clearance for the treatment of meibomian gland dysfunction, also known as evaporative dry eye.
Hybrid contact lens technology has existed for more than 30 years, and with each new wave of advances, its indications and market share have expanded.
Keeping up with developments in ophthalmic therapy could be a full-time job in itself, as new products are constantly tested and introduced, reformulated, given expanded indications, or withdrawn from the market.
Treatment of arterial and venous occlusive diseases often involves consultations with and referrals to ophthalmologists and retina specialists.
Primary care optometrists can take the lead in helping their older patients manage age-related health issues directly and indirectly associated with the eyes and vision.
In-vitro evaluations question epithelial barrier function with multi-purpose contact lens solution use
Biotrue and two other solutions with similar polyhexamethylene biguanide formulations did not alter corneal barrier function as compared with balanced salt solution and phosphate buffered saline controls.
Independent optometrists will increasingly need to differentiate themselves in their market. Forward-thinking eyewear designers offer an array of styles, shapes, colors, and materials that can help set your dispensary apart from the pack.
Treating both the medical and vision complaints of existing patients, in separate visits, is a low-cost strategy that generates significant additional income and meets patients' needs for comprehensive eye care.